No Data
Victory Square Technologies Reports Fiscal 2025 Results Highlighting Platform Scaling, Healthcare Infrastructure Growth and Portfolio Momentum
Hydreight Reports Record Fiscal 2025 Results as VSDHOne Drives Rapid Growth and Platform Scale
Hydreight Technologies Closes Strategic Investment in Insu Therapeutics
Hydreight Announces Normal Course Issuer Bid
Hydreight Technologies Inc. Announces Strategic Investment in Insu Therapeutics to Advance Needle-Free Peptide Delivery Technology
Hydreight Technologies: Strong 2026 Growth Guidance, Operating Leverage, and Discounted Valuation Support Buy Rating